CG Oncology, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin -23,796.57%-7,729.76%
EBIT Margin -27,180.88%-10,067.25%
EBITDA Margin -27,180.88%-10,067.25%
Operating Margin -27,180.88%-10,067.25%
Net Margin -33,234.31%-7,729.50%
FCF Margin -22,391.67%-6,931.26%
Efficiency
Assets Average 477.05M
Equity Average 305.14M
Invested Capital -123.10M733.38M
Asset Utilization Ratio 0.00
Leverage & Solvency
Equity Ratio -0.620.97
Valuation
Enterprise Value -187.67M1,197.62M
Market Capitalization 1,939.62M
Return Ratios
Return on Sales -237.97%-77.30%
Return on Capital Employed -0.25%
Return on Assets -0.18%
Return on Equity -0.29%